Check Cap Ltd
CHEK1.610USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
9.42MMarket Cap
LossP/E TTM
More Details of Check Cap Ltd Company
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Check Cap Ltd Info
Ticker SymbolCHEK
Company nameCheck Cap Ltd
IPO dateFeb 19, 2015
CEOOvadia (Alex)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 19
Address29 Abba Hushi Ave.
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code3009000
Phone97248303401
Websitehttps://check-cap.com/
Ticker SymbolCHEK
IPO dateFeb 19, 2015
CEOOvadia (Alex)
Company Executives of Check Cap Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
1.23K
+1.49%
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
950.00
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
752.00
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
211.00
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
Mr. Yuval Yanai
Mr. Yuval Yanai
Independent Director
Independent Director
--
--
Dr. Hanit Brenner-lavie
Dr. Hanit Brenner-lavie
Vice President - Clinical Affairs
Vice President - Clinical Affairs
--
--
Mr. Dan Hilerowitz
Mr. Dan Hilerowitz
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
1.23K
+1.49%
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
950.00
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
752.00
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
211.00
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
BNP Paribas Securities Corp. North America
0.31%
Dimensional Fund Advisors, L.P.
0.13%
Other
78.75%
Shareholders
Shareholders
Proportion
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
BNP Paribas Securities Corp. North America
0.31%
Dimensional Fund Advisors, L.P.
0.13%
Other
78.75%
Shareholder Types
Shareholders
Proportion
Corporation
15.69%
Individual Investor
5.13%
Research Firm
0.42%
Investment Advisor/Hedge Fund
0.17%
Bank and Trust
0.05%
Investment Advisor
0.02%
Other
78.53%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
31
46.22K
2.97%
--
2025Q3
31
46.22K
2.97%
-83.61K
2025Q2
30
129.91K
3.13%
+25.59K
2025Q1
31
104.32K
4.46%
-156.41K
2024Q4
32
147.67K
2.55%
+134.65K
2024Q3
33
13.02K
3.40%
+4.10K
2024Q2
36
9.37K
3.50%
-1.09K
2024Q1
41
13.66K
3.76%
-206.06K
2023Q4
43
68.48K
6.43%
+25.25K
2023Q3
45
28.34K
6.39%
+11.71K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
EquityLine Alternate Assets GP Inc
762.72K
10.86%
--
--
Dec 31, 2024
Ramanathan (Vijay)
360.00K
5.13%
--
--
Dec 31, 2024
Symetryx Corp
338.63K
4.82%
--
--
Dec 31, 2024
BNP Paribas Securities Corp. North America
20.14K
0.29%
+300.00
+1.51%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
8.96K
0.13%
--
--
Apr 30, 2025
Morgan Stanley & Co. LLC
4.00K
0.06%
+100.00
+2.56%
Jun 30, 2025
National Bank of Canada
3.27K
0.05%
+3.27K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
2.93K
0.04%
--
--
Aug 31, 2025
J.P. Morgan Securities LLC
1.71K
0.02%
-33.65K
-95.16%
Jun 30, 2025
Independent Financial Partners
500.00
0.01%
--
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Date
Type
Ratio
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
FAQs
Who are the top five shareholders of Check Cap Ltd?
The top five shareholders of Check Cap Ltd are:
EquityLine Alternate Assets GP Inc holds 762.72K shares, accounting for 10.86% of the total shares.
Ramanathan (Vijay) holds 360.00K shares, accounting for 5.13% of the total shares.
Symetryx Corp holds 338.63K shares, accounting for 4.82% of the total shares.
BNP Paribas Securities Corp. North America holds 20.14K shares, accounting for 0.29% of the total shares.
Dimensional Fund Advisors, L.P. holds 8.96K shares, accounting for 0.13% of the total shares.
EquityLine Alternate Assets GP Inc holds 762.72K shares, accounting for 10.86% of the total shares.
Ramanathan (Vijay) holds 360.00K shares, accounting for 5.13% of the total shares.
Symetryx Corp holds 338.63K shares, accounting for 4.82% of the total shares.
BNP Paribas Securities Corp. North America holds 20.14K shares, accounting for 0.29% of the total shares.
Dimensional Fund Advisors, L.P. holds 8.96K shares, accounting for 0.13% of the total shares.
What are the top three shareholder types of Check Cap Ltd?
The top three shareholder types of Check Cap Ltd are:
EquityLine Alternate Assets GP Inc
Ramanathan (Vijay)
Symetryx Corp
EquityLine Alternate Assets GP Inc
Ramanathan (Vijay)
Symetryx Corp
How many institutions hold shares of Check Cap Ltd (CHEK)?
As of 2025Q4, 31 institutions hold shares of Check Cap Ltd, with a combined market value of approximately 46.22K, accounting for 2.97% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Check Cap Ltd?
In --, the -- business generated the highest revenue for Check Cap Ltd, amounting to -- and accounting for --% of total revenue.
